Clinical effects of allylestrenol on prostatic hypertrophy
Kohri, K.; Kurita, T.; Iguchi, M.; Kataoka, K.
Hinyokika Kiyo. Acta Urologica Japonica 32(3): 486-492
1986
ISSN/ISBN: 0018-1994 PMID: 2425611 Document Number: 282882
Clinical effects of allylestrenol were studied on 26 patients with benign prostatic hypertrophy with urinary disturbances. Allylestrenol was administered at the dose of 50 mg/day given twice a day for more than 10 weeks. Evaluation of the drug efficacy was made based on urodynamic and ultrasonographic findings. One of the 26 cases dropped due to a side-effect (vertigo) and another due to defusal of treatment. The efficacy rate was 50%. Side-effects were observed in 2 cases (1 with decrease of potency and the other with vertigo) but were mild. It was concluded that allylestrenol is useful for treatment of urinary disturbances caused by prostatic hypertrophy.